Transmedics
TMDX
120 hedge funds and large institutions have $637M invested in Transmedics in 2021 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 49 increasing their positions, 25 reducing their positions, and 24 closing their positions.
96% more repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 25
87% more call options, than puts
Call options by funds: $7.55M | Put options by funds: $4.04M
1.4% more ownership
Funds ownership: 68.09% → 69.49% (+1.4%)
2% more capital invested
Capital invested by funds: $625M → $637M (+$11.5M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
3% less funds holding
Funds holding: 124 → 120 (-4)
13% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 24
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SAM
Silvercrest Asset Management
New York
|
+$6.29M |
| 2 |
NCGI
Next Century Growth Investors
Plymouth,
Minnesota
|
+$5.03M |
| 3 |
MAP
Moody Aldrich Partners
Marblehead,
Massachusetts
|
+$4.09M |
| 4 |
Calamos Advisors
Naperville,
Illinois
|
+$3.61M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$3.21M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$10.7M |
| 2 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$4.55M |
| 3 |
Millennium Management
New York
|
-$2.6M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$2.01M |
| 5 |
Two Sigma Investments
New York
|
-$1.78M |
TMDX Hedge Fund Activity: Q3 2021 in Review
120 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Transmedics (TMDX) for Q3 2021, worth a combined $637M — up 1.8% from $625M a quarter earlier.
Sellers outnumbered buyers: 24 funds closed out of TMDX and 21 opened new positions — a net loss of 3 holders — while 25 trimmed existing stakes and 49 added.
The largest buyer was Silvercrest Asset Management, opening a new position worth an estimated $6.29M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $10.7M sold.
- 120 institutional investors held Transmedics (TMDX) as of Q3 2021, down from 124 in Q2 2021.
- Funds reported $637M of Transmedics stock for Q3 2021, up 1.8% quarter-over-quarter.
- 21 funds opened new Transmedics positions in Q3 2021 and 24 closed out, a net change of -3 holders.
- The largest Transmedics buyer in Q3 2021 was Silvercrest Asset Management, an estimated $6.29M added.
- The largest Transmedics seller in Q3 2021 was Point72 Asset Management, an estimated $10.7M sold.
Based on aggregated 13F filings for Q3 2021.